| abstract |
The present disclosure provides an isolated binding molecule that binds to human 4-1BB, a nucleic acid molecule encoding an amino acid sequence of the binding molecule, a vector containing the nucleic acid molecule, a host cell containing the vector, and a method for preparing the binding molecule. , A pharmaceutical composition comprising the binding molecule, and a method for using the binding molecule or composition. |